logo
Some kids are in danger of getting addicted to their screens, new study suggests

Some kids are in danger of getting addicted to their screens, new study suggests

Yahoo18-06-2025
EDITOR'S NOTE: Kara Alaimo is an associate professor of communication at Fairleigh Dickinson University. Her book 'Over the Influence: Why Social Media Is Toxic for Women and Girls — And How We Can Take It Back' was published in 2024 by Alcove Press. Follow her on Instagram, Facebook and Bluesky.
If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website.
Many parents are worried about how much time our kids are spending on their screens. But a new study suggests that, to figure out how these platforms are affecting our kids, we need to focus on something else.
The amount of time kids spent on social media, mobile phones and video games wasn't associated with more internalizing symptoms of mental health problems such as anxiety and depression, according to the study published Wednesday, June 18 in JAMA, a journal of the American Medical Association. That time also wasn't associated with more externalizing symptoms of mental health problems, such as rule breaking and aggression — or with suicidal behaviors or suicidal ideation.
What mattered was whether they were getting addicted.
Addictive use is 'excessive use' that interferes with home responsibilities, schoolwork or other activities, said Yunyu Xiao, lead study author and an assistant professor in the department of population health sciences and department of psychiatry at Weill Cornell Medical College in New York. 'They find a craving for it and cannot stop using it.'
Almost half the young people studied were on a high trajectory of addictive use for mobile phones, and over 40% were on a high trajectory of addictive use for video games, according to the researchers.
Kids with high or increasing use of social media and mobile phones were at two to three times greater risk for suicidal behavior and suicidal ideations than the kids on the lower trajectory, according to the study of over 4,000 US children over a period of four years. The participants were 9 or 10 years old at the start of the study.
Other concerning results include: Young people whose social media use was high or increasing also had increased risks of symptoms of mental health problems. High use of video games was associated with greater risk of symptoms of mental health problems, suicidal behaviors and suicidal ideation.
Girls were more likely than boys to have high trajectories of addictive social media use, while boys were more likely to have high trajectories of addictive video game use.
Xiao acknowledged that the results were self-reported, and the study couldn't account for genetic or environmental factors that could have influenced the results.
The study makes clear that parents should try to help kids avoid these kinds of addictions.
'Set boundaries early on,' said Melissa Greenberg, a clinical psychologist at Princeton Psychotherapy Center in New Jersey. She was not involved in the study.
Kids should know that there are times when it's not OK to use cell phones, video games and other technology.
She also suggested scheduling screen-free time during meals and at night so your family can wind down before bed. She recommended not allowing phones into teens' bedrooms after a designated time each evening.
Greenberg also suggested encouraging — and, if necessary, planning — activities for teens that don't involve screens. When I talk to parents, I tell them to let their kids hang out with their friends more. A lot of parents worry about kids' safety when they get together in person, but it's often far more dangerous for them to be in their bedrooms on social media, where they could connect with predators or sextortionists or simply get addicted.
Also, 'model a healthy relationship with your own devices,' Greenberg said. 'Parents should be mindful of their own use of devices around their kids and show them by example how to balance screen time and screen-free time.'
The Anxious Generation, a movement sparked by Jonathan Haidt's eponymous book, ran a challenge last year, asking young people to commit to screen-free summer Fridays. Can you try doing it this summer with your kids?
This week, I've been speaking at training sessions for counselors at summer camps in Wisconsin and New England to try to convince them that if they put their phones away, they can have the best summer of their lives.
I point out that learning to get comfortable with ourselves and our own thoughts rather than pulling out a phone every time we have a spare moment is, unfortunately, a skill that requires practice these days. We can try it by going for walks (sans headphones), sitting and watching a sunset or lying around in a hammock. What could be more fun in the summer?
It's also important to talk to kids about how screens can be addictive 'in a nonjudgmental way,' Greenberg said. 'Screens are meant to grab our attention … and social media platforms are designed to keep us going back for more. It's important for us all to be aware of this.'
Finally, she said, parents should create device agreements with their kids, working together to decide things such as what kinds of use are acceptable and what the daily limits and consequences for breaking rules should be.
'Involve your teen in this process,' Greenberg recommended, so they understand the rationales.
Then, watch kids carefully to see whether these strategies are working. A key takeaway of the study is that 'if we do not examine their addictive use,' Xiao said, 'we will likely miss it.'
Signs that kids may be addicted include 'compulsive use or the uncontrollable urge' to use these platforms, Greenberg said. 'This may look like your teen frequently or constantly checking their phone every few minutes or turning to video games, even in situations where it's not appropriate or where they've been told not to' — such as at school, late at night or when they're doing homework.
Other signs of addiction are when kids try to reduce their use but can't follow the limits or when they get into trouble at school or work — or even annoy friends — because they're on their phones too much.
Kids who are addicted also may try to hide or lie about their use, then get defensive if parents ask about it, Greenberg said.
Also, 'symptoms of withdrawal are a classic sign of addiction,' Greenberg warned. Kids may end up anxious, irritable, sad or angry when they don't have access to their platforms, she said.
Another warning sign is when kids don't fulfill their responsibilities or engage in offline activities. 'This may look like teens not wanting to or feeling unable to engage in in-person interactions or feeling constantly distracted if they try,' Greenberg said. 'You may notice your teen not wanting to meet up with friends in person or not fulfilling responsibilities like homework or family responsibilities.'
Finally, parents should watch out for symptoms that kids aren't getting enough sleep. 'Phone and video game addiction can lead to lack of sleep when teens stay up late on their phones or playing video games and so end up sleep deprived, which can lead to fatigue, irritability, anxiety and/or depression,' Greenberg said.
If you think your child might be addicted, try not to be judgmental, Greenberg said. Keep in mind that they probably don't want to be addicted, and it isn't a sign you've failed as a parent. The problem is these devices seem to be designed to keep us hooked.
'We need to teach them, not shame them,' she said.
Talk to your child about how they're feeling and try to understand why they're spending so much time on these platforms, she said. Schedule other activities and make or revise your device agreement. 'If you already have one, talk through what is and is not working' and 'troubleshoot,' she said.
However, if the addiction seems to be having negative consequences or to be interfering with your child's functioning, seek help from a mental health professional, Greenberg advised.
This latest research suggests parents should worry less about the amount of time kids are spending on screens and more about whether they're exhibiting signs of addiction.
Parents can take steps to try to prevent it. However, if kids do appear to be addicted, it's important to get them help to avoid potentially serious outcomes.
Sign up for CNN's Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

West Nile Virus confirmed among mosquitoes in Macomb County
West Nile Virus confirmed among mosquitoes in Macomb County

CBS News

time24 minutes ago

  • CBS News

West Nile Virus confirmed among mosquitoes in Macomb County

West Nile Virus has been confirmed for the first time this summer among mosquitoes in Macomb County, Michigan, local health officials said Thursday. So far, there have been no confirmed human cases of West Nile Virus disease in Michigan. But the Macomb County Health Department said the virus is considered "endemic" in Macomb County in that it is regularly found among local mosquito populations. Because of those circumstances, the health department tests areas during spring and summer where mosquito populations are known to congregate. One of those samplings detected the presence of the virus. "This discovery by our surveillance team is important because it lets us know that this season's mosquitoes are now carrying the virus – which could spread to humans," Andrew Cox, director/health officer of Macomb County Health and Community Services, said in the announcement. Mosquitoes can become infected if they bite a bird that is infected with the virus. If the infected mosquitoes then bite humans, the health department explained, the disease can be transmitted to people. Many of those who are infected will have few to mild symptoms, such as fever or headache. But some people can develop serious complications such as encephalitis, which is inflammation of the brain, or meningitis, which is inflammation of the lining of the brain and spinal cord. People who are at greatest risk of becoming seriously ill include those age 50 and older, those who have received an organ transplant, or those with certain medical conditions such as diabetes or hypertension. Prevention tips To prevent getting West Nile Virus through a mosquito bite, the health department issues the following recommendations: Mosquitoes are most active from dusk to dawn. Those who are outside during that time should wear long pants and long sleeves to protect their skin. Use an insect repellent that contains DEET or picaridin on clothing and exposed skin. The Centers for Disease Control and Prevention suggests the use of oil of lemon eucalyptus should people prefer a more natural repellant. Any buckets, pools or pet dishes that hold standing water should be kept empty or changed frequently to prevent mosquitoes from using that water to lay eggs. Window and door screens should be kept in good repair to prevent mosquitoes from entering inside. The above video first aired Sept. 25, 2024.

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com
Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

Associated Press

time27 minutes ago

  • Associated Press

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the 'Company') announces that it submitted to an application to be able to file disclosure reports on OTCIQ. The application process includes a review by and is pending approval by [ This image cannot be displayed. Please visit the source: ] Evolutionary Biologics Ad Campaign To view an enhanced version of this graphic, please visit: James W. Zimbler, President, stated, 'Our application to resume submitting disclosure statements and financial information has been submitted and we are awaiting final approval. As soon as final approval is granted, we will be filing the necessary statements.' You can follow and contact the Company on X at @ApolloBioKOAN. About Apollo Biowellness, Inc. Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. We believe we are positioning our company as a leader in the field of Regenerative Medicine as defined by the National Institute of Health using biologic based products. Intended products are to be marketed under third-party label exemptions. We are focusing our current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Also, we are licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and professional markets. Before using any of our products, you should always consult with your veterinarian and/or family doctor. Forward-Looking StatementsCorporate Contact James W. Zimbler President/CEO/Director [email protected] 631-806-1420 To view the source version of this press release, please visit

GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat
GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat

Associated Press

time27 minutes ago

  • Associated Press

GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat

With COVID-19 continuing to mutate and over 40 million immunocompromised Americans still at risk, GeoVax's GEO-CM04S1 vaccine offers potential broader, more durable protection through a unique multi-antigen approach ATLANTA, GA - July 3, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today emphasized the urgent need for innovation in COVID-19 vaccination as the NB.1.8.1 variant - commonly known as 'Nimbus' - spreads rapidly across the globe. Nimbus, a highly transmissible Omicron subvariant classified by the World Health Organization as a 'Variant Under Monitoring,' is now dominant in multiple U.S. states and surging across Europe and Asia. Though not more severe, its rapid spread and potential for immune escape reflect an increasingly clear reality: COVID-19 is not going away, and it will continue to evolve. 'The emergence of the Nimbus variant is a stark reminder that we need 'smarter' vaccines, not just newer ones,' said David Dodd, Chairman and CEO of GeoVax. 'Our GEO-CM04S1 vaccine was designed for this purpose and is built to potentially provide broader and longer-lasting protection, especially for the immunocompromised patients most at risk.' GEO-CM04S1: Multi-Antigen Protection for the Immunocompromised Unlike mRNA vaccines that rely solely on the Spike protein, GEO-CM04S1 delivers both Spike (S) and Nucleocapsid (N) antigens, stimulating an immune response that includes not only an antibody response, but also robust T-cell activity. This is believed to be critical for cross-variant protection and extended durability, particularly in individuals with weakened immune systems. GEO-CM04S1 is currently being evaluated in two Phase 2 clinical trials, focused on populations at greatest risk from COVID-19 complications, including blood cancer patients scheduled to receive stem cell transplant therapy. In one of the ongoing Phase 2 trials, the mRNA control arm was discontinued due to poor immunogenicity with the remainder of the trial only including GEO-CM04S1 which surpassed the immunogenicity target, reinforcing the limitations of monovalent vaccines and the important value of a multi-antigen vaccine approach in such high-risk patient populations. 'There are more than 40 million immunocompromised individuals in the U.S. alone,' said Dodd. 'They are underserved by the current, FDA-approved vaccine options that deliver only an antibody response and require a better solution with both breadth and longevity of protection.' Public Vaccine Policy and Regulatory Changes Support Platform Diversification Recent guidance from the U.S. Food and Drug Administration (FDA) calls for diversified vaccine platforms and risk-based regulatory pathways. Additionally, the CDC's narrowed 2025–2026 booster recommendations - now focused on adults 65+ and immunocompromised individuals - closely mirror GeoVax's clinical strategy and target population. GEO-CM04S1 has been proposed under BARDA's Rapid Response Partnership Vehicle (RRPV) for surge manufacturing support and integration into long-term public health preparedness efforts. The proposal, 'Innovation in Clinical Manufacturing of MVA-Vectored COVID-19 Vaccines', was selected by the RRPV, pending funding availability. 'As public health moves toward more targeted, durable, and inclusive vaccination strategies, GEO-CM04S1 is positioned to deliver where first generation COVID-19 vaccines fall short,' Dodd added. In addition to targeting today's variants, GEO-CM04S1 is structurally designed to adapt to future mutations and serve as a platform for multi-pathogen preparedness. As part of GeoVax's broader MVA-based portfolio, the platform underpins vaccine candidates for Mpox, smallpox, and hemorrhagic fever viruses, offering scale and flexibility across infectious disease threats. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax is also developing a vaccine targeting Mpox and smallpox and, based on recent regulatory guidance, anticipates progressing directly to a Phase 3 clinical evaluation, omitting Phase 1 and Phase 2 trials. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words 'believe,' 'look forward to,' 'may,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'should,' 'plan,' 'could,' 'target,' 'potential,' 'is likely,' 'will,' 'expect' and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: [email protected] 678-384-7220 Investor Relations Contact: [email protected] 212-698-8696 Media Contact: Jessica Starman [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store